Search results
Results From The WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
In 1999, the therapeutics company was established under the name Nycomed as an independent company. In 2007, Nycomed took over the much larger German pharmaceutical company, Altana Pharma. This acquisition made Nycomed one of the world's 25 largest pharmaceutical companies. In 2007 Nycomed acquired American company Bradley Pharmaceuticals.
Altana was also admitted to trading on the New York Stock Exchange from 2002 to 2007. On 19 December 2006, the majority of shareholders voted to approve the sale of the pharmaceuticals division to the Danish company Nycomed. [7] Nycomed is owned by an investment consortium led by Nordic Capital and Credit Suisse.
On Friday, December 8, 2023, [12] shareholders approved the plan to split Solvay into two separate entities. [13] [14] As a result, Ilham Kadri, former CEO of Solvay, is the CEO of Syensqo, whereas Philippe Kehren becomes CEO of Solvay. [15] The split became effective on December 11th, 2023, with shares listed on Euronext Brussels and Euronext ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
In 1997, Amersham merged with Nycomed [7] to form Nycomed Amersham plc. In 1999, the Nycomed Pharma subsidiary was sold to Nordic Capital, [8] and in 2001 Nycomed Amersham plc was renamed to Amersham plc. [9] In 2004, Amersham was acquired by the American firm General Electric (GE) and incorporated into the GE Healthcare business segment. [10]
The survey's measure of new orders received by private businesses slipped to 54.3 in January from 55.2 in December. Price increases picked up, with a gauge of average prices paid by businesses for ...